Trial Details

RECRUITING
Basic Information
Clinical ID c992
Identifier NCT05287126
Trial Title A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod
Participant Information
Sponsor Pfizer
City Little Rock
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2022-12-16
Primary Completion Date 2027-07-14
Completion Date 2031-08-07